Through in vivo and in vitro experiments, our findings demonstrated that miR‐362 works as an anti‐oncomiR that inhibits proliferation and promotes apoptosis in cervical cancer cells via BAP31 and TGFβ/Smad pathway. The gene discussed is BCAP31; the disease is cervical carcinoma.